| Tumor microbiome metabolism: A game changer in cancer development and therapy X Zhou, S Kandalai, F Hossain, Q Zheng Frontiers in Oncology 12, 933407, 2022 | 19 | 2022 |
| Contributions of human-associated archaeal metabolites to tumor microenvironment and carcinogenesis M Cai, S Kandalai, X Tang, Q Zheng Microbiology Spectrum 10 (2), e0236721, 2022 | 19 | 2022 |
| The human microbiome and cancer: A diagnostic and therapeutic perspective S Kandalai, H Li, N Zhang, H Peng, Q Zheng Cancer Biology & Therapy 24 (1), 2240084, 2023 | 17 | 2023 |
| Applying multi‐omics toward tumor microbiome research N Zhang, S Kandalai, X Zhou, F Hossain, Q Zheng iMeta 2 (1), e73, 2023 | 13 | 2023 |
| Pathological pericyte expansion and impaired endothelial cell-pericyte communication in endothelial Rbpj deficient brain arteriovenous malformation S Selhorst*, S Nakisli*, S Kandalai, S Adhicary, CM Nielsen Frontiers in Human Neuroscience 16, 974033, 2022 | 6 | 2022 |
| Dynamic and wearable electro-responsive hydrogel with robust mechanical properties for drug release X Zhou, N Zhang, S Kandalai, H Li, F Hossain, S Zhang, J Zhu, J Zhang, ... ACS Applied Materials & Interfaces 15 (13), 17113-17122, 2023 | 5 | 2023 |
| Biosynthesis of D/L-lactate from methylglyoxal X Zhou*, N Zhang*, F Hossain, S Kandalai, H Tian, Q Zheng Tetrahedron 27, 133087, 2022 | 5 | 2022 |
| pH-responsive and recyclable hydrogels for gas-releasing and scavenging X Zhou*, S Kandalai*, F Hossain, N Zhang, H Li, Q Zheng Macromolecular Rapid Communications 44 (8), 2300008, 2023 | 4 | 2023 |
| Tunable toxicity of bufadienolides is regulated through a configuration inversion catalyzed by a short‐chain dehydrogenase/reductase G Ye*, W Huang*, Z Chen, H Zhong, J Zhong, X Guo, Y Huang, ... ChemBioChem 23 (22), 2022 | 3 | 2022 |
| Chemical and synthetic biology approaches for cancer vaccine development F Hossain, S Kandalai, X Zhou, N Zhang, Q Zheng Molecules 27 (20), 6933, 2022 | 2 | 2022 |
| Strain- and route-dependent plasma pharmacokinetics and DRG accumulation of paclitaxel T Drabison, Y Xu, E Ahmed, S Kandalai, K Hoyt, K Obrietan, S Hu, ... Journal of Pharmacology and Experimental Therapeutics 389 (S3), 2024 | | 2024 |
| Characterizing imatinib’s pharmacokinetics and impact on neuronal p-ERK signaling S Kandalai, J Stromatt, E Ahmed, N Halloy, L Steenrod, J Hoak, ... Journal of Pharmacology and Experimental Therapeutics 389 (S3), 2024 | | 2024 |
| Exploring causes of pericyte expansion in postnatal brain of Rbpj-mediated mouse model of arteriovenous malformation SM Kandalai Ohio University, 2021 | | 2021 |
Qingfei ZhengAssistant Professor, Department of Radiation Oncology, The Ohio State UniversityVerified email at osu.edu
